ASX Growth Companies With High Insider Ownership
As the Australian market searches for direction amidst fluctuating oil prices and global economic jitters, investors are keenly observing how these broader conditions impact local equities. In such an environment, growth companies with high insider ownership can be particularly appealing, as they often indicate strong management confidence and alignment with shareholder interests.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Torque Metals (ASX:TOR) | 18.6% | 94.2% |
| Starpharma Holdings (ASX:SPL) | 21.8% | 91.8% |
| SKS Technologies Group (ASX:SKS) | 28.2% | 42.4% |
| Predictive Discovery (ASX:PDI) | 10.4% | 65.1% |
| Pinnacle Investment Management Group (ASX:PNI) | 25% | 21.2% |
| Forrestania Resources (ASX:FRS) | 37.8% | 126.7% |
| Austral Resources Australia (ASX:AR1) | 20% | 38.7% |
| Auric Mining (ASX:AWJ) | 19.6% | 29.2% |
| Adveritas (ASX:AV1) | 17.6% | 108.4% |
| Advanced Energy Minerals (ASX:AEM) | 35.1% | 48.5% |
Let's dive into some prime choices out of the screener.
Chrysos (ASX:C79)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Chrysos Corporation Limited develops and supplies mining technologies across Europe, the Middle East, Africa, the Asia Pacific, and the Americas with a market cap of A$620.89 million.
Operations: The company's revenue is primarily derived from its Mining Services segment, which generated A$80.36 million.
Insider Ownership: 13.6%
Revenue Growth Forecast: 21.5% p.a.
Chrysos shows promising growth potential with its revenue expected to increase by 21.5% annually, outpacing the Australian market. Analysts anticipate a stock price rise of 74.5%. Although forecasted to become profitable in three years, Chrysos faces challenges with limited cash runway and low future return on equity (9.8%). Recent executive changes include the resignation of Ms Laura Goldsmith as Joint Company Secretary. Insider activity indicates more buying than selling over the past three months.
- Click to explore a detailed breakdown of our findings in Chrysos' earnings growth report.
- Our expertly prepared valuation report Chrysos implies its share price may be too high.
Clarity Pharmaceuticals (ASX:CU6)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Clarity Pharmaceuticals Ltd (ASX:CU6) is a clinical stage radiopharmaceutical company focused on developing radiopharmaceutical products for oncology in Australia and the United States, with a market cap of A$895.39 million.
Operations: The company generates revenue from its radiopharmaceutical development segment, amounting to A$10.58 million.
Insider Ownership: 13%
Revenue Growth Forecast: 50.1% p.a.
Clarity Pharmaceuticals demonstrates significant growth potential, with revenue projected to rise by 50.1% annually, surpassing the Australian market average. Despite recent insider selling, the company is expected to achieve profitability within three years. The recent A$9.76 million R&D Tax Incentive refund strengthens its financial position for further development of its Targeted Copper Theranostic platform. The new manufacturing agreement with Nucleus RadioPharma enhances Clarity's production capabilities and market access in the US and Europe.
- Unlock comprehensive insights into our analysis of Clarity Pharmaceuticals stock in this growth report.
- Our valuation report here indicates Clarity Pharmaceuticals may be overvalued.
GemLife Communities Group (ASX:GLF)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: GemLife Communities Group (ASX:GLF) operates as a developer, builder, owner, and operator in the land lease community sector in Australia with a market cap of A$1.71 billion.
Operations: The company generates revenue from its Development segment, amounting to A$259.83 million, and Community Operations, contributing A$21.86 million.
Insider Ownership: 26.7%
Revenue Growth Forecast: 14.4% p.a.
GemLife Communities Group, with a focus on governance enhancements, anticipates earnings growth of 21.4% annually, outpacing the Australian market. Despite slower revenue growth at 14.4%, it remains above market average. Recent board changes aim to bolster governance as GemLife continues its expansion. Insider activity shows more buying than selling recently, although not substantially so. Trading significantly below fair value estimates suggests potential upside in stock price according to analysts' consensus forecasts.
- Navigate through the intricacies of GemLife Communities Group with our comprehensive analyst estimates report here.
- Upon reviewing our latest valuation report, GemLife Communities Group's share price might be too pessimistic.
Seize The Opportunity
- Click through to start exploring the rest of the 98 Fast Growing ASX Companies With High Insider Ownership now.
- Seeking Other Investments? Trump has pledged to "unleash" American oil and gas and these 23 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com